Barclays PLC Pear Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$0.21 - $1.24 $3,658 - $21,600
17,420 Added 94.67%
35,820 $9,000
Q4 2022

Feb 13, 2023
BUY
$0.99 - $2.91 $15,340 - $45,090
15,495 Added 533.39%
18,400 $21,000
Q3 2022

Nov 03, 2022
BUY
$0.13 - $2.27 $377 - $6,594
2,905 New
2,905 $6,000

Others Institutions Holding PEAR

# of Institutions
2
Shares Held
23M
Call Options Held
0
Put Options Held
0
View Full List

About Pear Therapeutics, Inc.

PEAR Quotes by TradingView
  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email